U.S. federal trademark · Serial No. 75424289 · Reg. No. 2350638
Clinically tracking, monitoring and reviewing cancer chemotherapy drugs being utilized in the treatment of cancer, namely, prospectively reviewing cancer chemotherapy drug protocols, collecting pertinent and defined clinical data, and compiling and reporting of clinical data to health care providers and insurers to ensure that appropriate cost effective therapy and treatment is being provided to cancer patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.